VERA Vera Therapeutics Inc

Price (delayed)

$35.01

Market cap

$1.92B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.05

Enterprise value

$1.9B

Highlights
VERA's equity has soared by 124% year-on-year
VERA's EPS is up by 41% year-on-year and by 9% since the previous quarter
VERA's debt has soared by 74% year-on-year

Key stats

What are the main financial stats of VERA
Market
Shares outstanding
54.7M
Market cap
$1.92B
Enterprise value
$1.9B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.39
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$89.48M
EBITDA
-$92.37M
Free cash flow
-$99.78M
Per share
EPS
-$2.05
Free cash flow per share
-$1.96
Book value per share
$6.49
Revenue per share
$0
TBVPS
$8.23
Balance sheet
Total assets
$419.36M
Total liabilities
$65.81M
Debt
$53.26M
Equity
$353.54M
Working capital
$401.83M
Liquidity
Debt to equity
0.15
Current ratio
28.63
Quick ratio
27.76
Net debt/EBITDA
0.17
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-39.1%
Return on equity
-52.4%
Return on invested capital
-41.2%
Return on capital employed
-22.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VERA stock price

How has the Vera Therapeutics stock price performed over time
Intraday
2.7%
1 week
-5.99%
1 month
-2.45%
1 year
109.52%
YTD
127.63%
QTD
-3.23%

Financial performance

How have Vera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$101.87M
Net income
-$94.3M
Gross margin
N/A
Net margin
N/A
The net income has grown by 8% YoY
VERA's operating income is up by 3.1% year-on-year

Growth

What is Vera Therapeutics's growth rate over time

Valuation

What is Vera Therapeutics stock price valuation
P/E
N/A
P/B
5.39
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VERA's EPS is up by 41% year-on-year and by 9% since the previous quarter
VERA's equity has soared by 124% year-on-year
VERA's P/B is 9% less than its last 4 quarters average of 5.8

Efficiency

How efficient is Vera Therapeutics business performance
The ROIC has soared by 63% YoY and by 38% from the previous quarter
VERA's return on equity is up by 41% year-on-year and by 29% since the previous quarter
The ROA has increased by 40% year-on-year and by 23% since the previous quarter

Dividends

What is VERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VERA.

Financial health

How did Vera Therapeutics financials performed over time
VERA's total assets has surged by 139% since the previous quarter and by 100% year-on-year
The total liabilities has increased by 27% year-on-year but it has declined by 11% since the previous quarter
VERA's debt is 85% smaller than its equity
VERA's equity has soared by 124% year-on-year
VERA's debt has soared by 74% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.